Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2005 Apr 11;92(7):1329-35.
doi: 10.1038/sj.bjc.6602450.

Recent trends in cancer mortality in the UK

Affiliations
Comparative Study

Recent trends in cancer mortality in the UK

R Doll et al. Br J Cancer. .

Abstract

Comparisons of survival rates of given diseases with different treatments or in different places often gave misleading results until the introduction of controlled trials. Recent reports of relatively low survival rates following the treatment of cancer in the UK compared to the rates in other countries, not based on controlled trials, may consequently be misleading. Their validity has, therefore, been tested by comparing the levels and trends in mortality--the ultimate criterion by which the success or failure of any system of care can be judged. For this purpose, rates and trends in rates over 20-50 years have been compared in five European countries of similar economic status (France, Italy, the Netherlands, Sweden, and the UK). The UK rates are not generally worse than those in the other countries and are sometimes better. Exceptions were cancer of the lung, large bowel, and breast, the first of which is explained by differences in the prevalence of smoking.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Five EU countries, 1979–2001, Males: testis cancer mortality at all ages. *Annual rates per 100 000 men, standardised to conventional European age distribution. Source: WHO mortality and UN population estimates.
Figure 2
Figure 2
Five EU countries, 1979–2002, Males: Hodgkin's disease mortality at all ages. *Annual rates per 100 000 men, standardised to conventional European age distribution. Source: WHO mortality and UN population estimates.
Figure 3
Figure 3
Five EU countries, 1979–2002, Females: Hodgkin's disease mortality at all ages. *Annual rates per 100 000 women, standardised to conventional European age distribution. Source: WHO mortality and UN population estimates.
Figure 4
Figure 4
Five EU countries, 1950–2002, Males: stomach cancer mortality at all ages. *Annual rates per 100 000 men, standardised to conventional European age distribution. Source: WHO mortality and UN population estimates.
Figure 5
Figure 5
Five EU countries, 1950–2002, Females: stomach cancer mortality at all ages. *Annual rates per 100 000 women, standardised to conventional European age distribution. Source: WHO mortality and UN population estimates.
Figure 6
Figure 6
Five EU countries, 1950–2002, Males: lung cancer mortality at all ages. *Annual rates per 100 000 men, standardised to conventional European age distribution. Source: WHO mortality and UN population estimates.
Figure 7
Figure 7
Five EU countries, 1950–2002, Females: lung cancer mortality at all ages. *Annual rates per 100 000 women, standardised to conventional European age distribution. Source: WHO mortality and UN population estimates.
Figure 8
Figure 8
Trends in lung cancer at ages 40–44 and past cigarette smoking in men and women in France 1950–2000. (A) Average number of cigarettes per day between age 15 and 42.5, population aged 40–44. (B) Lung cancer death rate, population aged 40–44.
Figure 9
Figure 9
Five EU countries, 1950–2002, Females: breast cancer mortality at all ages. *Annual rates per 100 000 women, standardised to conventional European age distribution. Source: WHO mortality and UN population estimates.
Figure 10
Figure 10
Five EU countries, 1950–2002, Males: prostate cancer mortality at all ages. *Annual rates per 100 000 men, standardised to conventional European age distribution. Source: WHO mortality and UN population estimates.
Figure 11
Figure 11
Five EU countries, 1950–2002, Males: colorectal cancer mortality at all ages. *Annual rates per 100 000 men, standardised to conventional European age distribution. Source: WHO mortality and UN population estimates.
Figure 12
Figure 12
Five EU countries, 1950–2002, Females: colorectal cancer mortality at all ages. *Annual rates per 100 000 women, standardised to conventional European age distribution. Source: WHO mortality and UN population estimates.
Figure 13
Figure 13
Five EU countries, 1950–2002, Males: all cancer (excl. lung) mortality at all ages. *Annual rates per 100 000 men, standardised to conventional European age distribution. Source: WHO mortality and UN population estimates.
Figure 14
Figure 14
Five EU countries, 1950–2002, Females: all cancer (excl. lung) mortality at all ages. *Annual rates per 100 000 women, standardised to conventional European age distribution. Source: WHO mortality and UN population estimates.

Similar articles

Cited by

References

    1. Early Breast Cancer Trialists' Collaborative Group (1988) Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. New Engl J Med 319: 1681–1692 - PubMed
    1. International Agency for Research on Cancer (1992) In Cancer Incidence in Five Continents Parkin DM, Miur CS, Whelan SL, Gao Y-T, Ferlay J, Powell J (eds), Vol 6 International Agency for Research on Cancer: Lyon, 1992
    1. Sant M, Aareleid T, Berrino F, Bielska LM, Carli PM, Faivre J, Grosclaude P, Hedelin G, Matsuda T, Moller H, Moller T, Verdecchia A, Capocaccia R, Gatta G, Micheli A, Santaquilani M, Roazzi P, Lisi D (2003) EUROCARTE-3 survival of cancer patients diagnosed 1990–94-results and commentary. Ann Oncol 14(Suppl 5): v61–v118 - PubMed

Publication types